Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia

NCT06696833 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

B-Cell Acute Lymphoblastic Leukemia, Adult

Interventions

BIOLOGICAL: QH10304-BAL-01
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

The First Affiliated Hospital of Soochow University